Date: 2016-11-08
Type of information: Financing round
Company: Curevac (Germany)
Investors: Baden-Württembergische Versorgungsanstalt für Ärzt (Germany) Zahnärzte und Tierärzte (via the LBBW Asset Management Investmentgesellschaft (Germany) Landeskreditbank Baden-Württemberg (Germany)
Amount: $29.5 million
Funding type: financing round
Planned used: These funds will be used to advance the development of its messenger RNA (mRNA) product portfolio.
Others:
- • On November 8, 2016, CureVac announced that the company secured a total of $29.5 million in a financing led by new investors Baden-Württembergische Versorgungsanstalt für Ärzte, Zahnärzte und Tierärzte (via the LBBW Asset Management Investmentgesellschaft mbH, Stuttgart) and Landeskreditbank Baden-Württemberg.
The new investors join earlier investors that participated in the company’s financing in November 2015, where CureVac raised a total of $110 million (€100 million).
Therapeutic area:
Is general: Yes
